Prevention of preterm birth by progestational agents: What are the molecular mechanisms?

Christopher Nold, Monique Maubert, Lauren Anton, Steven Yellon, Michal A. Elovitz

Research output: Contribution to conferencePaperpeer-review

Original languageEnglish
Pages223.e1-223.e7
DOIs
StatePublished - Mar 2013
Event33rd annual meeting of the Society for Maternal-Fetal Medicine - San Francisco, United States
Duration: Feb 11 2013Feb 16 2016

Conference

Conference33rd annual meeting of the Society for Maternal-Fetal Medicine
Country/TerritoryUnited States
CitySan Francisco
Period2/11/132/16/16

ASJC Scopus Subject Areas

  • Obstetrics and Gynecology

Keywords

  • cervical remodeling
  • preterm birth
  • progesterone
  • MicroRNAs/genetics
  • Cervix Uteri/drug effects
  • Progesterone/administration & dosage
  • Premature Birth/drug therapy
  • Administration, Intravaginal
  • Cyclooxygenase 2/genetics
  • Uterus/drug effects
  • Hydroxyprogesterones/administration & dosage
  • Pregnancy
  • Animals
  • STAT5 Transcription Factor/genetics
  • 17 alpha-Hydroxyprogesterone Caproate
  • Homeodomain Proteins/genetics
  • Connexin 43/genetics
  • Female
  • Mice
  • Receptors, Oxytocin/genetics
  • Kruppel-Like Transcription Factors/genetics
  • Uterine Contraction/drug effects
  • Zinc Finger E-box-Binding Homeobox 1

Cite this